Healthcare - Biotechnology - NASDAQ - US
$ 4.76
-5.18 %
$ 326 M
Market Cap
-1.25
P/E
Price Target
Average
8.04%
Revenue Forecast
Estimate
--50.91%
EBIT
Estimate
--9.63%
Net Income
Estimate
--17.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amylyx Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AMLX of $5.14 , with forecasts ranging from a low of $3 to a high of $10 .
AMLX Lowest Price Target
Wall Street Target
3 USD
-36.97%
AMLX Average Price Target
Wall Street Target
5.14 USD
8.04%
AMLX Highest Price Target
Wall Street Target
10 USD
110.08%
REVENUE FORECAST
Revenue Forecast Chart AMLX
EBIT FORECAST
EBIT Forecast Chart AMLX
NET INCOME FORECAST
Net Income Chart AMLX